With drug counterfeiting growing at an alarming rate both in the United States and abroad, it was appropriate that this subject was addressed at the recent Federation Internationale Pharmaceutique (FIP) annual meeting, Pharmacy and Pharmaceutical Sciences World Congress 2004, held in New Orleans. FIP is a worldwide organization of national professional associations of pharmacists and pharmaceutical scientists.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.